loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2006_307___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Abbott Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ABBOTT LABORATORIES Abbott Park US (1)

    filter

    01 Terazosin hydrochloride dihydrate (1)

    filter

    01 India (1)

    filter

    01 Suspended by EDQM Failure to CEP procedure (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    ABBOTT LABORATORIES Abbott Park US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Terazosin hydrochloride dihydrate

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2006-307 - Rev 01
    Suspended by EDQM F...
    Chemical
    2013-03-21
    2023-03-16
    2021
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2006-307 - Rev 01 of Abbott Laboratories Abbott Park Us

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2006-307 - Rev 01 of Abbott Laboratories Abbott Park Us 1

    20

    Abbott Laboratories Abbott Park Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their significant offerings is Terazosin hydrochloride dihydrate, supported by a 'Suspended by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 2006-307 - Rev 01

    This Chemical Type CEP, issued on March 21, 2013, remains in force until March 16, 2023, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2021 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY